Top Questions in Uncomplicated, Non–Staphylococcus aureus Bacteremia-Reference-Cited by-同舟云学术

Top Questions in Uncomplicated, Non–Staphylococcus aureus Bacteremia

Published:2018-04-21 Issue:5 Volume:5 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Sutton Jesse D¹^ORCID,Sayood Sena²,Spivak Emily S³

Affiliation:

1. Department of Pharmacy, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah

2. Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah

3. Department of Medicine, Division of Infectious Diseases, University of Utah School of Medicine & Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah

Abstract

Abstract The Infectious Diseases Society of America infection-specific guidelines provide limited guidance on the management of focal infections complicated by secondary bacteremias. We address the following 3 commonly encountered questions and management considerations regarding uncomplicated bacteremia not due to Staphylococcus aureus: the role and choice of oral antibiotics focusing on oral beta-lactams, the shortest effective duration of therapy, and the role of repeat blood cultures.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/article-pdf/5/5/ofy087/33591429/ofy087.pdf

Reference91 articles.

1. Does this adult patient with suspected bacteremia require blood cultures;Coburn;JAMA,2012

2. Blood culture status and mortality among patients with suspected community-acquired bacteremia: a population-based cohort study;Søgaard;BMC Infect Dis,2011

3. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America;Mermel;Clin Infect Dis,2009

4. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults;Mandell;Clin Infect Dis,2007

5. Variability of treatment duration for bacteraemia in the critically ill: a multinational survey;Corona;J Antimicrob Chemother,2003

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Follow-up Blood Cultures With Mortality in Patients With Gram-Negative Bloodstream Infections;JAMA Network Open;2022-09-22

2. Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial;Trials;2022-07-19

3. The Changing Landscape of Uncomplicated Gram-Negative Bacteremia: A Narrative Review to Guide Inpatient Management;Journal of Hospital Medicine;2020-08-19

4. Oral antibiotic therapy in people who inject drugs (PWID) with bacteraemia;Swiss Medical Weekly;2020-06-21

5. Impact of an antimicrobial stewardship bundle for uncomplicated gram-negative bacteremia;Open Forum Infectious Diseases;2019-11-13